TAPIRS Technique Plus Adjustable Compression System in Treatment of Venous

Status Not yet recruiting

Clinical Trial Summary

The aim of this study is to determine the percentage of healing of active venous ulcers following Terminal Axial Perforator Interruption Reflux Source (tapirs technique) and adjustable compression system versus a control group using the traditional multilayer bandages.

Clinical Trial Description

Venous ulcer due to venous insufficiency causes an important morbidity to those people suffering from this condition. Most of therapies available under the obligatory health plan (POS, acronym in Spanish) to date cover the cleaning of the ulcerous lesion and its medical handling using saline solutions, topical antibiotics and elastic dressings, implying an important intake from health resources due to its chronicity and the delay in ulcers healing, which usually takes periods ranging from 12 months to several years. Therapeutic alternatives, which can guarantee optimal, fast and persistent in time healing, should be identified.

The aim of this study is to determine the percentage of healing of active venous ulcers (using a clinical, etiological, anatomic and physiopathologic classification (CEAP), C6) following Endovascular Laser Treatment (EVLT) of axial vein hypertension plus ultrasound-guided foam sclerotherapy of superficial venous reflux under knee, closing perforator veins and terminal reflux under de ulcer in patients with chronic venous ulceration (TAPIRS technique) plus compression with an adjustable compression system (juxta cures) versus a control group using the traditional multilayer bandages. The investigators expect that the minimal surgical invasive approach closing all the superficial venous reflux plus adjustable compression system will diminish the time of ulcer healing compared with standard treatment of multilayer bandage care. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02798445
Study type	Interventional
Source	Hospital Occidente de Kennedy
Contact	ernesto nieves, md
Phone	573108800230
Email	ernestonieves1@hotmail.com
Status	Not yet recruiting
Phase	N/A
Start date	June 2016
Completion date	June 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05633277` - Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections	N/A
Recruiting	`NCT02838784` - Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers	N/A
Completed	`NCT02092870` - Adipose Derived Regenerative Cellular Therapy of Chronic Wounds	Phase 2
Terminated	`NCT00847002` - Flexitouch Treatment for Venous Ulcers	N/A
Completed	`NCT01858272` - Preliminary Testing of New Treatment for Chronic Leg Wounds	Phase 1
Not yet recruiting	`NCT05877378` - Efficacy of PICO Single-use System in Chronic Ulcers	N/A
Recruiting	`NCT05409976` - The GORE® VIAFORT Vascular Stent IVC Study	N/A
Terminated	`NCT01396304` - Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers	Phase 4
Not yet recruiting	`NCT06007703` - Evaluation of the Efficacy of Multilayer Compression & UrgoStart Plus
Completed	`NCT04046120` - Comparison of the Effectiveness of Two Medical Compression Bandage Application Techniques by Measuring Interface Pressures Depending on Whether or Not the Heel is Included in Patients With Open Venous Ulcers	N/A
Terminated	`NCT04021316` - Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration	N/A
Completed	`NCT05729334` - Clinical Investigation EUCLIDES-01 for the Calculation of the Area of Skin Lesions	N/A
Completed	`NCT03070938` - PuraPly™ Antimicrobial Wound Matrix and Wound Management	N/A
Terminated	`NCT01853384` - Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers	Phase 3
Completed	`NCT00558662` - Randomized Clinical Trial (RCT) to Compare the Efficacy of Coban 2 Versus SSB in the Treatment of Venous Leg Ulcers	N/A
Completed	`NCT01750749` - Cell Therapy for Venous Leg Ulcers Pilot Study	Phase 1
Completed	`NCT01327937` - A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers	Phase 4
Completed	`NCT00820196` - A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study)	Phase 2
Completed	`NCT00301496` - Randomized Controlled 8-Week Crossover Evaluation of Compression Bandage Systems for Venous Leg Ulcers	N/A
Recruiting	`NCT05489588` - The GORE® VIAFORT Vascular Stent Iliofemoral Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

TAPIRS Technique Plus Adjustable Compression System in Treatment of Venous Leg Ulcers — TAPIRS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms